Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

Keith Lindor

doi:10.1056/NEJMct074694

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

Keith Lindor

Research output: Contribution to journal › Article › peer-review

84 Scopus citations

Abstract

A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.

Original language	English (US)
Pages (from-to)	1524
Number of pages	1
Journal	New England Journal of Medicine
Volume	357
Issue number	15
DOIs	https://doi.org/10.1056/NEJMct074694
State	Published - Oct 11 2007
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMct074694

Cite this

@article{bfa0628daeeb4b3e811649ac30010afc,

title = "Ursodeoxycholic acid for the treatment of primary biliary cirrhosis",

abstract = "A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.",

author = "Keith Lindor",

note = "Funding Information: This work was supported in part by Synthelabo-Re-cberche. The Canadian participation in the ~tudywassup parted by Jouveinal, Interfalk, and C.M.R. This work was conducted under the auspices of the {\textquoteleft}Association Frangaise par I{\textquoteright}Etude du Foie{\textquoteright}.",

year = "2007",

month = oct,

day = "11",

doi = "10.1056/NEJMct074694",

language = "English (US)",

volume = "357",

pages = "1524",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

AU - Lindor, Keith

N1 - Funding Information: This work was supported in part by Synthelabo-Re-cberche. The Canadian participation in the ~tudywassup parted by Jouveinal, Interfalk, and C.M.R. This work was conducted under the auspices of the ‘Association Frangaise par I’Etude du Foie’.

PY - 2007/10/11

Y1 - 2007/10/11

N2 - A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.

AB - A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.

UR - http://www.scopus.com/inward/record.url?scp=35248893940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35248893940&partnerID=8YFLogxK

U2 - 10.1056/NEJMct074694

DO - 10.1056/NEJMct074694

M3 - Article

C2 - 17928600

AN - SCOPUS:35248893940

SN - 0028-4793

VL - 357

SP - 1524

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 15

ER -

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this